CGEN vs REGN: Which Stock is Better?
Side-by-side comparison of Compugen Ltd and Regeneron Pharmaceuticals Inc in 2026
CGEN
Compugen Ltd
$2.83
REGN
Regeneron Pharmaceuticals Inc
$766.02
Key Metrics Comparison
| Metric | CGEN | REGN | Winner |
|---|---|---|---|
| Market Cap | $269.72M | $78.93B | REGN |
| P/E Ratio | 7.47 | 17.99 | CGEN |
| EPS (TTM) | $0.38 | $41.51 | REGN |
| Revenue Growth | 44.8% | 0.0% | CGEN |
| Gross Margin | 87.3% | 44.6% | CGEN |
Analyze CGEN
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGEN or REGN a better investment?
Comparing CGEN and REGN: Compugen Ltd has a market cap of $269.72M while Regeneron Pharmaceuticals Inc has $78.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGEN and REGN?
CGEN (Compugen Ltd) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGEN or REGN?
Based on P/E ratios, CGEN trades at a lower multiple (7.5x vs 18.0x).
Which is growing faster: CGEN or REGN?
CGEN has higher revenue growth at 44.8% vs 0.0% for REGN.
Which company is more profitable: CGEN or REGN?
Compugen Ltd (CGEN) has higher gross margins at 87.3% compared to 44.6% for REGN.
Which is the larger company: CGEN or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.93B compared to $269.72M for CGEN.
Should I buy CGEN or REGN in 2026?
Both CGEN and REGN have investment merit. CGEN trades at $2.83 while REGN trades at $766.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGEN and REGN stock?
Key differences: Market Cap ($269.72M vs $78.93B), P/E Ratio (7.5x vs 18.0x), Revenue Growth (44.8% vs 0.0%), Gross Margin (87.3% vs 44.6%).